Literature DB >> 16908408

Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport.

Jacob U Fog1, Habibeh Khoshbouei, Marion Holy, William A Owens, Christian Bjerggaard Vaegter, Namita Sen, Yelyzaveta Nikandrova, Erica Bowton, Douglas G McMahon, Roger J Colbran, Lynette C Daws, Harald H Sitte, Jonathan A Javitch, Aurelio Galli, Ulrik Gether.   

Abstract

Efflux of dopamine through the dopamine transporter (DAT) is critical for the psychostimulatory properties of amphetamines, but the underlying mechanism is unclear. Here we show that Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) plays a key role in this efflux. CaMKIIalpha bound to the distal C terminus of DAT and colocalized with DAT in dopaminergic neurons. CaMKIIalpha stimulated dopamine efflux via DAT in response to amphetamine in heterologous cells and in dopaminergic neurons. CaMKIIalpha phosphorylated serines in the distal N terminus of DAT in vitro, and mutation of these serines eliminated the stimulatory effects of CaMKIIalpha. A mutation of the DAT C terminus impairing CaMKIIalpha binding also impaired amphetamine-induced dopamine efflux. An in vivo role for CaMKII was supported by chronoamperometry measurements showing reduced amphetamine-induced dopamine efflux in response to the CaMKII inhibitor KN93. Our data suggest that CaMKIIalpha binding to the DAT C terminus facilitates phosphorylation of the DAT N terminus and mediates amphetamine-induced dopamine efflux.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16908408     DOI: 10.1016/j.neuron.2006.06.028

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  117 in total

Review 1.  Vesicular and plasma membrane transporters for neurotransmitters.

Authors:  Randy D Blakely; Robert H Edwards
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

Review 2.  The solute carrier 6 family of transporters.

Authors:  Stefan Bröer; Ulrik Gether
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder.

Authors:  Erica Bowton; Christine Saunders; Kevin Erreger; Dhananjay Sakrikar; Heinrich J Matthies; Namita Sen; Tammy Jessen; Roger J Colbran; Marc G Caron; Jonathan A Javitch; Randy D Blakely; Aurelio Galli
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

4.  The plasma membrane-associated GTPase Rin interacts with the dopamine transporter and is required for protein kinase C-regulated dopamine transporter trafficking.

Authors:  Deanna M Navaroli; Zachary H Stevens; Zeljko Uzelac; Luke Gabriel; Michael J King; Lawrence M Lifshitz; Harald H Sitte; Haley E Melikian
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

5.  Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression.

Authors:  M A Cervinski; J D Foster; R A Vaughan
Journal:  Neuroscience       Date:  2010-07-17       Impact factor: 3.590

Review 6.  Protein kinases and addiction.

Authors:  Anna M Lee; Robert O Messing
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

7.  Reassessment of models of facilitated transport and cotransport.

Authors:  Richard J Naftalin
Journal:  J Membr Biol       Date:  2010-03-05       Impact factor: 1.843

8.  N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux.

Authors:  B Torres; A E Ruoho
Journal:  Neuroscience       Date:  2013-12-07       Impact factor: 3.590

9.  Proline-directed phosphorylation of the dopamine transporter N-terminal domain.

Authors:  Balachandra K Gorentla; Amy E Moritz; James D Foster; Roxanne A Vaughan
Journal:  Biochemistry       Date:  2009-02-10       Impact factor: 3.162

10.  Structural and Functional Characterization of the Interaction of Snapin with the Dopamine Transporter: Differential Modulation of Psychostimulant Actions.

Authors:  Amaia M Erdozain; Stéphanie De Gois; Véronique Bernard; Victor Gorgievski; Nicolas Pietrancosta; Sylvie Dumas; Carlos E Macedo; Peter Vanhoutte; Jorge E Ortega; J Javier Meana; Eleni T Tzavara; Vincent Vialou; Bruno Giros
Journal:  Neuropsychopharmacology       Date:  2017-09-14       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.